CompuGroup Medical SE & Co. KGaA (COP) - Net Assets
Based on the latest financial reports, CompuGroup Medical SE & Co. KGaA (COP) has net assets worth €652.09 Million EUR (≈ $762.36 Million USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.02 Billion ≈ $2.36 Billion USD) and total liabilities (€1.37 Billion ≈ $1.60 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CompuGroup Medical SE & Co. KGaA liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €652.09 Million |
| % of Total Assets | 32.31% |
| Annual Growth Rate | 16.83% |
| 5-Year Change | 1.47% |
| 10-Year Change | 236.59% |
| Growth Volatility | 64.07 |
CompuGroup Medical SE & Co. KGaA - Net Assets Trend (2004–2024)
This chart illustrates how CompuGroup Medical SE & Co. KGaA's net assets have evolved over time, based on quarterly financial data. Also explore CompuGroup Medical SE & Co. KGaA assets under control for the complete picture of this company's asset base.
Annual Net Assets for CompuGroup Medical SE & Co. KGaA (2004–2024)
The table below shows the annual net assets of CompuGroup Medical SE & Co. KGaA from 2004 to 2024. For live valuation and market cap data, see COP stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €648.31 Million ≈ $757.94 Million |
-3.13% |
| 2023-12-31 | €669.27 Million ≈ $782.45 Million |
-0.68% |
| 2022-12-31 | €673.82 Million ≈ $787.77 Million |
+10.05% |
| 2021-12-31 | €612.28 Million ≈ $715.82 Million |
-4.17% |
| 2020-12-31 | €638.94 Million ≈ $746.98 Million |
+145.82% |
| 2019-12-31 | €259.92 Million ≈ $303.87 Million |
-4.79% |
| 2018-12-31 | €273.00 Million ≈ $319.16 Million |
+15.65% |
| 2017-12-31 | €236.06 Million ≈ $275.98 Million |
+7.96% |
| 2016-12-31 | €218.65 Million ≈ $255.63 Million |
+13.52% |
| 2015-12-31 | €192.61 Million ≈ $225.18 Million |
+9.67% |
| 2014-12-31 | €175.63 Million ≈ $205.33 Million |
-8.83% |
| 2013-12-31 | €192.64 Million ≈ $225.21 Million |
+7.37% |
| 2012-12-31 | €179.41 Million ≈ $209.75 Million |
+6.66% |
| 2011-12-31 | €168.20 Million ≈ $196.65 Million |
-7.95% |
| 2010-12-31 | €182.73 Million ≈ $213.63 Million |
-1.67% |
| 2009-12-31 | €185.83 Million ≈ $217.25 Million |
+1.64% |
| 2008-12-31 | €182.82 Million ≈ $213.74 Million |
-7.67% |
| 2007-12-31 | €198.02 Million ≈ $231.50 Million |
+264.18% |
| 2006-12-31 | €54.37 Million ≈ $63.57 Million |
+20.87% |
| 2005-12-31 | €44.98 Million ≈ $52.59 Million |
+55.80% |
| 2004-12-31 | €28.87 Million ≈ $33.76 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CompuGroup Medical SE & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €53.73 Million | 8.29% |
| Other Components | €594.18 Million | 91.71% |
| Total Equity | €647.91 Million | 100.00% |
CompuGroup Medical SE & Co. KGaA Competitors by Market Cap
The table below lists competitors of CompuGroup Medical SE & Co. KGaA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CAP S.A
SN:CAP
|
$1.17 Billion |
|
China Railway Tielong Container Logistics Co Ltd
SHG:600125
|
$1.17 Billion |
|
El Puerto de Liverpool S.A.B. de C.V
MX:LIVEPOLC-1
|
$1.17 Billion |
|
Medartis Holding AG
SW:MED
|
$1.17 Billion |
|
Lithium Argentina AG
NYSE:LAR
|
$1.17 Billion |
|
Barloworld Ltd
JSE:BAW
|
$1.17 Billion |
|
Limin Chemical Co Ltd
SHE:002734
|
$1.17 Billion |
|
Guizhou Redstar Developing Co Ltd
SHG:600367
|
$1.17 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CompuGroup Medical SE & Co. KGaA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 667,678,000 to 647,914,000, a change of -19,764,000 (-3.0%).
- Net income of 34,600,000 contributed positively to equity growth.
- Dividend payments of 51,735,000 reduced retained earnings.
- Share repurchases of 14,642,000 reduced equity.
- Other comprehensive income decreased equity by 719,148,000.
- Other factors increased equity by 731,161,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €34.60 Million | +5.34% |
| Dividends Paid | €51.73 Million | -7.98% |
| Share Repurchases | €14.64 Million | -2.26% |
| Other Comprehensive Income | €-719.15 Million | -110.99% |
| Other Changes | €731.16 Million | +112.85% |
| Total Change | €- | -2.96% |
Book Value vs Market Value Analysis
This analysis compares CompuGroup Medical SE & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.85x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 39.07x to 1.85x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | €0.58 | €22.66 | x |
| 2005-12-31 | €0.92 | €22.66 | x |
| 2006-12-31 | €1.20 | €22.66 | x |
| 2007-12-31 | €3.91 | €22.66 | x |
| 2008-12-31 | €3.48 | €22.66 | x |
| 2009-12-31 | €3.67 | €22.66 | x |
| 2010-12-31 | €3.63 | €22.66 | x |
| 2011-12-31 | €3.36 | €22.66 | x |
| 2012-12-31 | €3.62 | €22.66 | x |
| 2013-12-31 | €3.80 | €22.66 | x |
| 2014-12-31 | €3.53 | €22.66 | x |
| 2015-12-31 | €3.87 | €22.66 | x |
| 2016-12-31 | €4.38 | €22.66 | x |
| 2017-12-31 | €4.71 | €22.66 | x |
| 2018-12-31 | €5.41 | €22.66 | x |
| 2019-12-31 | €5.24 | €22.66 | x |
| 2020-12-31 | €11.89 | €22.66 | x |
| 2021-12-31 | €11.55 | €22.66 | x |
| 2022-12-31 | €12.86 | €22.66 | x |
| 2023-12-31 | €12.73 | €22.66 | x |
| 2024-12-31 | €12.27 | €22.66 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CompuGroup Medical SE & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.34%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.00%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 3.03x
- Recent ROE (5.34%) is below the historical average (15.41%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 37.49% | 11.28% | 0.64x | 5.23x | €7.23 Million |
| 2005 | 36.86% | 13.24% | 0.82x | 3.38x | €11.19 Million |
| 2006 | 10.75% | 99.86% | 0.03x | 4.05x | €407.08K |
| 2007 | 11.78% | 12.78% | 0.65x | 1.43x | €3.48 Million |
| 2008 | 0.70% | 0.54% | 0.56x | 2.31x | €-16.84 Million |
| 2009 | 6.33% | 3.90% | 0.66x | 2.44x | €-6.79 Million |
| 2010 | 9.20% | 5.37% | 0.56x | 3.05x | €-1.47 Million |
| 2011 | 5.73% | 2.43% | 0.62x | 3.81x | €-7.17 Million |
| 2012 | 17.12% | 6.82% | 0.69x | 3.63x | €12.78 Million |
| 2013 | 12.26% | 5.04% | 0.66x | 3.67x | €4.27 Million |
| 2014 | 14.80% | 5.05% | 0.70x | 4.20x | €8.44 Million |
| 2015 | 20.02% | 7.09% | 0.69x | 4.12x | €19.26 Million |
| 2016 | 20.44% | 7.95% | 0.69x | 3.71x | €22.75 Million |
| 2017 | 13.34% | 5.37% | 0.71x | 3.52x | €7.83 Million |
| 2018 | 35.47% | 13.40% | 0.85x | 3.13x | €69.00 Million |
| 2019 | 25.40% | 8.83% | 0.70x | 4.11x | €39.91 Million |
| 2020 | 11.46% | 8.74% | 0.53x | 2.45x | €9.33 Million |
| 2021 | 11.27% | 6.73% | 0.57x | 2.93x | €7.76 Million |
| 2022 | 10.92% | 6.50% | 0.58x | 2.89x | €6.17 Million |
| 2023 | 6.88% | 3.87% | 0.63x | 2.85x | €-20.85 Million |
| 2024 | 5.34% | 3.00% | 0.59x | 3.03x | €-30.19 Million |
Industry Comparison
This section compares CompuGroup Medical SE & Co. KGaA's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $35,440,843
- Average return on equity (ROE) among peers: -606.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CompuGroup Medical SE & Co. KGaA (COP) | €652.09 Million | 37.49% | 2.10x | $1.17 Billion |
| CERTIVE SOLUTIONS INC. (5CE) | $-10.47 Million | 0.00% | 0.00x | $296.62K |
| IQ-AI LTD. LS -01 (5Y1) | $707.07K | -72.35% | 0.70x | $144.21K |
| NIGHTINGALE HEALTH EO 1 (7XE) | $97.36 Million | -18.57% | 0.10x | $47.63 Million |
| TRELLUS HEALTH LS -0006 (85Q) | $19.50 Million | -32.51% | 0.04x | $159.96K |
| SPOTLITE360 IOT SOLUTIONS (87A0) | $295.66K | -4766.19% | 10.32x | $916.43K |
| DocCheck AG (AJ91) | $18.82 Million | 3.55% | 0.15x | $58.35 Million |
| MeVis Medical Solutions AG (M3V) | $33.73 Million | 19.97% | 0.35x | $45.14 Million |
| Nexus AG (NXU) | $123.58 Million | 12.07% | 0.81x | $1.24 Billion |
About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells management software for registered physicians, medical car… Read more